SEDIA Trademark

Trademark Overview

On Thursday, August 31, 2017, a trademark application was filed for SEDIA with the United States Patent and Trademark Office. The USPTO has given the SEDIA trademark a serial number of 87592527. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, March 22, 2024. This trademark is owned by Sedia Biosciences Corporation. The SEDIA trademark is filed in the Medical Instrument Products category with the following description:

Medical diagnostic apparatus for testing blood for the presence of autoimmune disorders and conditions in humans
sedia

General Information

Serial Number87592527
Word MarkSEDIA
Filing DateThursday, August 31, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, March 22, 2024
Registration Number5467608
Registration DateTuesday, May 15, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 27, 2018

Trademark Statements

Goods and ServicesMedical diagnostic apparatus for testing blood for the presence of autoimmune disorders and conditions in humans

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSaturday, September 9, 2017
Primary Code010
First Use Anywhere DateWednesday, August 26, 2009
First Use In Commerce DateWednesday, August 26, 2009

Trademark Owner History

Party NameSedia Biosciences Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBeaverton, OR 97008
Party NameSedia Biosciences Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPortland, OR 97230
Party NameSedia Biosciences Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPortland, OR 97230

Trademark Events

Event DateEvent Description
Friday, March 22, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, March 22, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, March 22, 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Thursday, March 21, 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Thursday, March 21, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, September 26, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, May 15, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 29, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 29, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 29, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 29, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 29, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 15, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, February 27, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 27, 2018PUBLISHED FOR OPPOSITION
Wednesday, February 7, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 19, 2018ASSIGNED TO LIE
Tuesday, January 9, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 12, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 12, 2017NON-FINAL ACTION E-MAILED
Tuesday, December 12, 2017NON-FINAL ACTION WRITTEN
Wednesday, December 6, 2017ASSIGNED TO EXAMINER
Saturday, September 9, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 4, 2017NEW APPLICATION ENTERED

Related Keywords

sedia autoimmune disorders conditions humans presence blood diagnostic apparatus testing medical